WebApr 11, 2024 · Compared with using chemotherapy alone, anti-angiogenic agents, targeted therapy, and immunotherapy can provide more benefits in survival rate for recurrent … WebCommonly known as drug resistance, this phenomenon is one of the most challenging problems facing cancer researchers and patients today. When cancer cells resist the effects of drugs used for treatment, they can grow …
Detection of Chemotherapy-resistant Pancreatic Cancer Using a …
WebFeb 1, 2024 · Resistance to cytotoxic chemotherapy is a major clinical problem and substantial research is ongoing into potential methods of overcoming this resistance. One major target, the receptor tyrosine kinase MET, has generated increasing interest with multiple clinical trials in progress. WebSep 20, 2024 · Oct. 16, 2024 — Multidrug resistance (MDR) -- a process in which tumors become resistant to multiple medicines -- is the main cause of failure of cancer chemotherapy. Tumor cells often acquire ... force outlook to download all folders
Frontiers Treatment options for recurrent platinum-resistant …
WebPlatinum-resistant ovarian cancer has an overall poor prognosis with a modest response to cytotoxic chemotherapy and as such it represents a daily challenge for patients and the caring team. Understanding the tumor microenvironment and its prognostic value in treating advanced or recurrent ovarian cancer, immunotherapy is promising and exciting ... Web1 day ago · Recent studies have also focused on the relevance between MMR function and chemotherapy resistance. Either abnormal expression of or mutations in MMR genes can lead to the emergence of drug resistance (Table 2). MMR status is an effective means to predict the response to adjuvant 5-FU-based chemotherapy in CRC patients [21]. WebFeb 24, 2024 · As a result, Dr. Jenniffer Linares, first author of the study, states that, "we have discovered a mechanism of resistance to platinum-based chemotherapy and a marker of this resistance in patients ... force outlook to check for mail